latest news releases from the newsroom
NASDAQ Announces End-of-Month Open Short Interest Positions in NASDAQ Stocks as of Settlement Date November 28, 2008
NEW YORK, Dec. 9, 2008 (GLOBE NEWSWIRE) -- At the end of the settlement date of November 28, 2008, short interest in 2,580 NASDAQ Global Market(sm) securities totaled 7,366,379,401 shares compared with 7,272,722,628 shares in 2,597 Global Market issues reported for the prior settlement date of November 14, 2008. The end-of-November short interest represents 3.11 days average daily NASDAQ Global Market share volume for the reporting period, compared with 3.20 days for the prior reporting period.
VistaPrint Announces Share Repurchase Activities
HAMILTON, Bermuda, Dec. 9, 2008 (GLOBE NEWSWIRE) -- VistaPrint Limited (Nasdaq:VPRT), the small business marketing company, today announced that through December 5, 2008, under its previously-announced $50 million share repurchase program, the company repurchased 2,517,885 common shares for approximately $45.0 million, at an average cost per share of $17.86.
Hutchinson Technology Inc
Hutchinson Technology Announces Restructuring Plan
HUTCHINSON, Minn., Dec. 9, 2008 (GLOBE NEWSWIRE) -- Hutchinson Technology Incorporated (Nasdaq:HTCH) today announced a restructuring plan that includes a 20-25% reduction of its workforce, which totaled approximately 4,500 at the end of November. The company estimates that its financial results for its fiscal 2009 first quarter ending December 28, 2008 will include a charge of $12 million to $16 million related to severance costs. In addition, the company will be implementing a 5% pay reduction for all employees not affected by the workforce reduction. The workforce and pay reductions are expected to be complete by the end of January 2009 and are part of the company's strategy to manage its cash and balance sheet and reduce its overall cost structure by approximately $65 million to $80 million on an annualized basis. The company's plans also include reducing its fiscal year 2009 capital spending from $60 million to $40 million.
OXiGENE Stockholders Approve Share Issuance to Symphony Capital
WALTHAM, Mass., Dec. 9, 2008 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (XSSE:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that during a special meeting of stockholders held on December 9, 2008, stockholders approved the proposal to issue additional shares of the Company's common stock to Symphony ViDA Holdings LLC, related to the previously announced formation of Symphony ViDA, Inc. Symphony ViDA was established by OXiGENE and Symphony to develop OXi4503, OXiGENE's dual-mechanism, second-generation vascular disrupting agent (VDA), and topical-route ZYBRESTAT for ophthalmology.
LTX-Credence Announces First Quarter Results
MILPITAS, Calif., Dec. 9, 2008 (GLOBE NEWSWIRE) -- LTX-Credence Corporation (Nasdaq:LTXC), a global provider of focused, cost-optimized ATE solutions, today announced financial results for its 2009 first fiscal quarter ended October 31, 2008. Today's announcement is the first release of combined financial results following the merger of LTX Corporation and Credence Systems Corporation on August 29, 2008, and therefore includes Credence's operating results from August 29, 2008 to October 31, 2008 and a full quarter of LTX's operating results.